FDA NDC Directory · JSON-LD · Markdown

ZALEPLON

NDC 57237-239 · HUMAN PRESCRIPTION DRUG · CAPSULE

Labeler / ManufacturerRising Pharma Holdings, Inc.
Marketing categoryAbbreviated NDA (generic) · App ANDA078829
Dosage form / routeCAPSULE · ORAL
Active ingredientsZALEPLON (5 mg/1)
Marketing started20080606
Package count1

External sources

Source: openFDA. Public-domain (CC0).